InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Ginkgo Bioworks Holdings, Inc.

DNA Clue Score24
United States Fiscal year ends December CIK 0001830214
$13.00 +14.64% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $13.00 +37.28% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 19 Apr 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Revenue54.2Operating income−71.6Net income−119.3EPS, diluted−0.10Fiscal year 2020Revenue76.7 +41.5%Operating income−137.0Net income−126.6EPS, diluted−0.10Fiscal year 2021Revenue313.8 +309.4%Operating income−1,828.5Net income−1,830.0EPS, diluted−1.39Fiscal year 2022Revenue477.7 +52.2%Operating income−2,209.0Net income−2,104.9EPS, diluted−50.20Fiscal year 2023Revenue251.5 −47.4%Operating income−864.4Net income−892.9EPS, diluted−18.37Fiscal year 2024Revenue227.0 −9.7%Operating income−559.8Net income−547.0EPS, diluted−10.54Fiscal year 2025Revenue170.2 −25.1%Operating income−315.3Net income−312.8EPS, diluted−5.64
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 54.2 76.7 313.8 477.7 251.5 227.0 170.2
Growth +41.5% +309.4% +52.2% −47.4% −9.7% −25.1%
Operating income −71.6 −137.0 −1,828.5 −2,209.0 −864.4 −559.8 −315.3
Net income −119.3 −126.6 −1,830.0 −2,104.9 −892.9 −547.0 −312.8
Growth
EPS, diluted −0.10 −0.10 −1.39 −50.20 −18.37 −10.54 −5.64

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2019Operating margin−132.1%Net margin−220.2%Free cash flow margin−123.4%Fiscal year 2020Operating margin−178.8%Net margin−165.2%Free cash flow margin−252.6%Fiscal year 2021Operating margin−582.6%Net margin−583.1%Free cash flow margin−98.9%Fiscal year 2022Operating margin−462.4%Net margin−440.6%Free cash flow margin−63.7%Fiscal year 2023Operating margin−343.8%Net margin−355.1%Free cash flow margin−133.7%Fiscal year 2024Operating margin−246.5%Net margin−240.9%Free cash flow margin−168.3%Fiscal year 2025Operating margin−185.3%Net margin−183.8%Free cash flow margin−105.0%
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −132.1% −178.8% −582.6% −462.4% −343.8% −246.5% −185.3%
Net margin −220.2% −165.2% −583.1% −440.6% −355.1% −240.9% −183.8%
Free cash flow margin −123.4% −252.6% −98.9% −63.7% −133.7% −168.3% −105.0%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow−44.7Capital expenditure−22.2Free cash flow−66.9Buybacks−0.4Fiscal year 2020Operating cash flow−135.8Capital expenditure−57.8Free cash flow−193.7Fiscal year 2021Operating cash flow−253.8Capital expenditure−56.5Free cash flow−310.3Fiscal year 2022Operating cash flow−252.2Capital expenditure−52.3Free cash flow−304.5Fiscal year 2023Operating cash flow−295.5Capital expenditure−40.8Free cash flow−336.3Fiscal year 2024Operating cash flow−319.6Capital expenditure−62.5Free cash flow−382.1Fiscal year 2025Operating cash flow−171.1Capital expenditure−7.7Free cash flow−178.7
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −44.7 −135.8 −253.8 −252.2 −295.5 −319.6 −171.1
Capital expenditure −22.2 −57.8 −56.5 −52.3 −40.8 −62.5 −7.7
Free cash flow −66.9 −193.7 −310.3 −304.5 −336.3 −382.1 −178.7
Growth
Buybacks −0.4 n/a n/a n/a n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2019Cash495.3Shareholders’ equity493.1Fiscal year 2020Cash380.8Shareholders’ equity461.4Fiscal year 2021Cash1,550.0Shareholders’ equity1,505.4Fiscal year 2022Cash1,315.8Shareholders’ equity1,736.3Fiscal year 2023Cash944.1Shareholders’ equity1,097.2Fiscal year 2024Cash561.6Shareholders’ equity716.1Fiscal year 2025Cash167.2Shareholders’ equity508.6
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 495.3 380.8 1,550.0 1,315.8 944.1 561.6 167.2
Shareholders’ equity 493.1 461.4 1,505.4 1,736.3 1,097.2 716.1 508.6

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022† 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
54.2 76.7 313.8 477.7 251.5 227.0 170.2
Growth +41.5% +309.4% +52.2% −47.4% −9.7% −25.1%
96.3 159.8 1,149.7 1,052.6 580.6 424.1 243.8
29.5 38.3 863.0 1,429.8 385.0 246.2 183.3
−71.6 −137.0 −1,828.5 −2,209.0 −864.4 −559.8 −315.3
Growth
−119.8 −124.8 −1,838.1 −2,121.4 −892.9 −547.5 −313.6
0.0 1.9 −1.5 −15.0 −0.1 −0.5 −0.8
−119.3 −126.6 −1,830.0 −2,104.9 −892.9 −547.0 −312.8
Growth
Per share
−0.10 −0.10 −1.35 −50.15 −18.37 −10.54 −5.64
−0.10 −0.10 −1.39 −50.20 −18.37 −10.54 −5.64
Growth
1,149 1,275 1,360 42.0 48.6 51.9 55.5
1,149 1,275 1,360 42.0 48.6 51.9 55.5
Growth +10.9% +6.7% −96.9% +15.8% +6.8% +6.9%

† The diluted share count jumps at 2022, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 17.3% a year over five years.
  • Operating margin is down 6.5 points on five years ago, at -185.3%.
  • A net loss in 7 of 7 years on file.